News | August 04, 2021
Dr Reddy’s relaunch Naproxen Sodium Tablets in the US
It is part of the company’s pain/analgesics portfolio of OTC products
It is part of the company’s pain/analgesics portfolio of OTC products
Ibuprofen and Famotidine tablets approved by FDA
_logo_256_384.jpg){kind=logo}
It supports sequencing-based COVID 19 surveillance in India
Complementary business models are the reason for the acquisition
It works as an adjunct to standard care based on robust clinical trials
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
Turnover of API division of ISLL stood at Rs 856.58 crore
The group now has 320 approvals and has so far filed over 400 ANDAs
It posted net loss of Rs.(2429.81) crores for the period ended June 30, 2020.
The company posted net profit of Rs.89.20 crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
